(Q73895528)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Novel phenylpiperazine derivatives as dual cytokine regulators with TNF-alpha suppressing and IL-10 augmenting activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

T Hanano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

K Adachi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Y Aoki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Morimoto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Y Naka

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Hisadome

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Fukuda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

H Sumichika

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

875-879

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Tumor necrosis factor in the serum of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Thalidomide inhibits the replication of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Potent inhibition of tumor necrosis factor-alpha production by tetrafluorothalidomide and tetrafluorophthalimides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-alpha production: effects of the stereoisomers of (3-hydroxycyclopentyl)adenines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

Effect of endotoxin on cytokine production and cell dynamics in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900128-1

7 January 2021

10.1016/S0960-894X(00)00128-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10853650%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference